| 000 | 01851 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515001436.0 | ||
| 264 | 0 | _c20060307 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0884-0431 | ||
| 024 | 7 |
_a10.1359/JBMR.050602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorwitz, Mara J | |
| 245 | 0 | 0 |
_aContinuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cOct 2005 |
||
| 300 |
_a1792-803 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcitriol _xblood |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercalcemia _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteoblasts _xmetabolism |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aParathyroid Hormone-Related Protein _xadministration & dosage |
| 650 | 0 | 4 |
_aTeriparatide _xadministration & dosage |
| 700 | 1 | _aTedesco, Mary Beth | |
| 700 | 1 | _aSereika, Susan M | |
| 700 | 1 | _aSyed, Mushtaq A | |
| 700 | 1 | _aGarcia-Ocaña, Adolfo | |
| 700 | 1 | _aBisello, Alessandro | |
| 700 | 1 | _aHollis, Bruce W | |
| 700 | 1 | _aRosen, Clifford J | |
| 700 | 1 | _aWysolmerski, John J | |
| 700 | 1 | _aDann, Pamela | |
| 700 | 1 | _aGundberg, Caren | |
| 700 | 1 | _aStewart, Andrew F | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 20 _gno. 10 _gp. 1792-803 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1359/JBMR.050602 _zAvailable from publisher's website |
| 999 |
_c15794043 _d15794043 |
||